Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 5 BMI and cardiorespiratory fitness levels

Published byPhyllis Short Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 5 BMI and cardiorespiratory fitness levels"— Presentation transcript:

1 Figure 5 BMI and cardiorespiratory fitness levels
Figure 5 | BMI and cardiorespiratory fitness levels. Kaplan-Meier analyses according to BMI with the a | low cardiorespiratory fitness (CRF) group (O2 consumption <14 mLO2 kg−1 min−1, log rank 11.7, P = 0.003) and b | high CRF group (O2 consumption ≥14 mLO2 kg−1 min−1, log rank 1.72, P = 0.42). BMI is expressed as kg/m2. Reproduced from Lavie, C. J. et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin. Proc. 88, 251–258 (2013), with permission from Elsevier. Reproduced from Lavie, C. J. et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin. Proc. 88, 251–258 (2013), with permission from Elsevier Lavie, C. J. et al. (2017) Management of cardiovascular diseases in patients with obesity Nat. Rev. Cardiol. doi: /nrcardio

Download ppt "Figure 5 BMI and cardiorespiratory fitness levels"

Similar presentations

A GRADUATING RESEARCH PROJECT FOR THE BACHALOLIC DEGEES.

A GRADUATING RESEARCH PROJECT FOR THE BACHALOLIC DEGEES.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 10 Assessment of myocardial fibrosis

Figure 10 Assessment of myocardial fibrosis
Reproduced with permission from Yancy, C. W. et al. 2017

Reproduced with permission from Yancy, C. W. et al. 2017
Figure 8 Implanted devices for the management of heart failure

Figure 8 Implanted devices for the management of heart failure
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 BMI and mortality in patients with heart failure

Figure 4 BMI and mortality in patients with heart failure
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 Two approaches to therapeutic genome editing

Figure 5 Two approaches to therapeutic genome editing
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.

Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 3 Global rates of sodium, fruit, and vegetable intake
Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.

Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.
Figure 2 Size categorization of airborne pollutants

Figure 2 Size categorization of airborne pollutants
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition

Figure 2 Three-year survival rates on the basis of body composition

Similar presentations

Ads by Google